http://news.bbc.co.uk/1/hi/health/7584868.stm
Is it too simplistic to say that if the NHS has £1.75 billion surplus that it hasn't spent, NICE could perhaps consider re-evaluating the cost-effectiveness criteria by which it is decided whether the NHS can afford to provide certain drugs? I'm sure everyone would rather this surplus was spent on the kidney cancer, dementia and other drugs that have been reported as not being available to people over the past few weeks, than have it sit in the Treasury coffers.
Tags: